Agilent Beats Q4 Expectations but Posts Soft Guidance

• Jefferies set a price target of $130 for Agilent Technologies (NYSE:A), while the stock was trading at $142.31, indicating a potential overvaluation according to Jefferies.
• Citi analysts maintain a 'Buy' rating on Agilent, with a target price of $165, highlighting the company's strong growth outlook and earnings leverage.
• Agilent's stock price has shown resilience with a current trading price of $141.64, reflecting a year-to-date increase amidst market fluctuations.

Agilent Technologies (NYSE:A) is a global leader in life sciences, diagnostics, and applied chemical markets. The company provides instruments, software, services, and consumables for the entire laboratory workflow. Agilent's competitors include Thermo Fisher Scientific and PerkinElmer. On October 3, 2025, Jefferies set a price target of $130 for Agilent, while the stock was trading at $142.31, indicating a price difference of approximately -8.65% from the target.

Citi analysts recently held a "constructive" meeting with Agilent's management, highlighting growth drivers for the company into the next year. These factors are expected to translate into earnings leverage, as noted by the analysts. Agilent's management expressed confidence in the company's growth outlook for fiscal 2026, supported by strong margins in its fiscal fourth quarter of 2025 and fiscal 2026.

Agilent is well-positioned to benefit from strong topline and volume growth, the Ignite initiative, and easing tariff impacts. Citi analysts have maintained a 'Buy' rating on Agilent's stock, setting a target price of $165 per share. Despite this positive outlook, Agilent shares experienced a slight decline of 0.5%, closing at $137.96 on Thursday.

Currently, Agilent's stock is priced at $141.64, reflecting an increase of 2.12% or $2.94. Today, the stock has traded as low as $138.86 and as high as $143.09. Over the past year, the stock has reached a high of $153.84 and a low of $96.43. The company has a market capitalization of approximately $40.16 billion, with a trading volume of 1,916,720 shares on the NYSE.

Agilent Technologies (NYSE:A) reported fourth-quarter earnings that exceeded analyst expectations, but its fiscal 2025 guidance came in below projections.

For the quarter ending, Agilent posted adjusted earnings per share (EPS) of $1.46, surpassing the Street consensus estimate of $1.41. Revenue increased by 0.8% year-over-year to $1.70 billion, also beating the expected $1.67 billion. Despite the strong quarter, the company’s outlook dampened investor sentiment.

Agilent projected full-year fiscal 2025 adjusted EPS in the range of $5.54 to $5.61, falling short of the $5.66 analysts anticipated. Revenue guidance of $6.79 billion to $6.87 billion was roughly in line with the Street consensus estimate of $6.83 billion.

Looking ahead to the first quarter of 2025, Agilent forecast revenue between $1.65 billion and $1.68 billion, representing a range of -0.5% to +1.3% year-over-year growth. Adjusted EPS for the quarter is expected to fall between $1.25 and $1.28.

• Agilent Technologies (NYSE:A) reported earnings per share (EPS) of $1.46, surpassing the estimated $1.41.
• The company's revenue for the quarter was approximately $1.7 billion, exceeding the estimated $1.67 billion.
• Agilent's financial health is indicated by a price-to-earnings (P/E) ratio of 29.84 and a current ratio of 2.09.

Agilent Technologies (NYSE:A) is a prominent player in the electronics testing equipment industry. The company specializes in providing analytical instruments, software, services, and consumables for the entire laboratory workflow. Agilent's competitors include Thermo Fisher Scientific and Danaher Corporation. The company recently reported its financial results for the fourth quarter of fiscal year 2024, showcasing its strong performance.

On November 25, 2024, Agilent reported earnings per share (EPS) of $1.46, surpassing the estimated $1.41. This marks a 3.55% earnings surprise, as highlighted by Zacks. The company has consistently outperformed consensus EPS estimates over the past four quarters, demonstrating its ability to exceed market expectations. In the previous quarter, Agilent also reported a positive earnings surprise of 5.60%.

Agilent's revenue for the quarter was approximately $1.7 billion, exceeding the estimated $1.67 billion. This represents a 1.65% revenue surprise, according to Zacks. The company has surpassed consensus revenue estimates in three of the last four quarters. Despite a slight decline of 0.3% in core revenue compared to the same quarter in 2023, Agilent's reported revenue increased by 0.8%.

During the Q4 2024 earnings call, CEO Padraig McDonnell and CFO Bob McMahon discussed the company's financial performance and strategic direction. Agilent's new market-based, customer-first strategy and organizational transformation are expected to enhance growth opportunities. The call was attended by analysts from major financial institutions, including Citi, Goldman Sachs, JPMorgan, and Bank of America.

Agilent's financial metrics provide insight into its market valuation and financial health. The company's price-to-earnings (P/E) ratio is approximately 29.84, while its price-to-sales ratio stands at about 5.94. The enterprise value to sales ratio is around 6.25, and the enterprise value to operating cash flow ratio is approximately 22.79. Agilent's debt-to-equity ratio is about 0.57, and its current ratio is around 2.09, indicating a strong ability to cover short-term liabilities.

• Agilent Technologies (NYSE:A) reported earnings per share (EPS) of $1.46, surpassing the estimated $1.41.
• The company's revenue for the quarter was approximately $1.7 billion, exceeding the estimated $1.67 billion.
• Agilent's financial health is indicated by a price-to-earnings (P/E) ratio of 29.84 and a current ratio of 2.09.

Agilent Technologies (NYSE:A) is a prominent player in the electronics testing equipment industry. The company specializes in providing analytical instruments, software, services, and consumables for the entire laboratory workflow. Agilent's competitors include Thermo Fisher Scientific and Danaher Corporation. The company recently reported its financial results for the fourth quarter of fiscal year 2024, showcasing its strong performance.

On November 25, 2024, Agilent reported earnings per share (EPS) of $1.46, surpassing the estimated $1.41. This marks a 3.55% earnings surprise, as highlighted by Zacks. The company has consistently outperformed consensus EPS estimates over the past four quarters, demonstrating its ability to exceed market expectations. In the previous quarter, Agilent also reported a positive earnings surprise of 5.60%.

Agilent's revenue for the quarter was approximately $1.7 billion, exceeding the estimated $1.67 billion. This represents a 1.65% revenue surprise, according to Zacks. The company has surpassed consensus revenue estimates in three of the last four quarters. Despite a slight decline of 0.3% in core revenue compared to the same quarter in 2023, Agilent's reported revenue increased by 0.8%.

During the Q4 2024 earnings call, CEO Padraig McDonnell and CFO Bob McMahon discussed the company's financial performance and strategic direction. Agilent's new market-based, customer-first strategy and organizational transformation are expected to enhance growth opportunities. The call was attended by analysts from major financial institutions, including Citi, Goldman Sachs, JPMorgan, and Bank of America.

Agilent's financial metrics provide insight into its market valuation and financial health. The company's price-to-earnings (P/E) ratio is approximately 29.84, while its price-to-sales ratio stands at about 5.94. The enterprise value to sales ratio is around 6.25, and the enterprise value to operating cash flow ratio is approximately 22.79. Agilent's debt-to-equity ratio is about 0.57, and its current ratio is around 2.09, indicating a strong ability to cover short-term liabilities.

Agilent Technologies (NYSE:A) is a global leader in life sciences, diagnostics, and applied chemical markets. The company provides instruments, software, services, and consumables for the entire laboratory workflow. As Agilent prepares to release its quarterly earnings on November 25, 2024, analysts expect an earnings per share (EPS) of $1.41 and revenue of $1.67 billion.

The anticipated EPS of $1.41 represents a 2.2% increase from the previous year, as highlighted by analysts. However, the projected revenue of $1.67 billion marks a slight decrease of 0.9% year-over-year. This stability in earnings estimates over the past 30 days suggests that analysts are confident in their forecasts, which can influence investor sentiment.

Historically, Agilent's stock has shown mixed reactions following earnings reports, with an equal number of positive and negative next-day returns over the past eight quarters. On average, the stock has moved 5.3% in either direction post-earnings in the last two years. However, options markets are currently pricing in a larger potential swing of 7.6% this time.

Agilent's stock price is currently up 0.9% at $126.83, recovering from its lowest close since July and potentially ending a four-day losing streak. The company's financial ratios, such as a P/E ratio of 27.10 and a price-to-sales ratio of 5.84, reflect investor confidence in its earnings and revenue potential. The debt-to-equity ratio of 0.50 indicates a moderate level of debt, while a current ratio of 1.78 suggests good liquidity.

Agilent Technologies (NYSE:A) is a global leader in life sciences, diagnostics, and applied chemical markets. The company provides instruments, software, services, and consumables for the entire laboratory workflow. As Agilent prepares to release its quarterly earnings on November 25, 2024, analysts expect an earnings per share (EPS) of $1.41 and revenue of $1.67 billion.

The anticipated EPS of $1.41 represents a 2.2% increase from the previous year, as highlighted by analysts. However, the projected revenue of $1.67 billion marks a slight decrease of 0.9% year-over-year. This stability in earnings estimates over the past 30 days suggests that analysts are confident in their forecasts, which can influence investor sentiment.

Historically, Agilent's stock has shown mixed reactions following earnings reports, with an equal number of positive and negative next-day returns over the past eight quarters. On average, the stock has moved 5.3% in either direction post-earnings in the last two years. However, options markets are currently pricing in a larger potential swing of 7.6% this time.

Agilent's stock price is currently up 0.9% at $126.83, recovering from its lowest close since July and potentially ending a four-day losing streak. The company's financial ratios, such as a P/E ratio of 27.10 and a price-to-sales ratio of 5.84, reflect investor confidence in its earnings and revenue potential. The debt-to-equity ratio of 0.50 indicates a moderate level of debt, while a current ratio of 1.78 suggests good liquidity.